Trades on 1 secondary market

Labgenius

LabGenius Therapeutics is a London-based drug discovery company that combines machine learning, high-throughput robotic experimentation and synthetic biology to discover and co-optimise next-generation therapeutic antibodies for solid tumours. Its EVA (Experimental Vector Automation) platform is a c

emerging 15.0 / 100 0 APIs View provider profile →

Company Biotechnology Drug Discovery Therapeutics Antibodies Machine Learning

Labgenius is an API provider whose private shares are listed on 1 secondary market: EquityZen.

Where It Trades

EZ EquityZen View listing →

Listing data is compiled from the public marketplace pages of Forge Global, Hiive, EquityZen, Nasdaq Private Market, and Augment. A listing indicates that a venue has published a page for this company — it is not an offer, a quote, or investment advice, and APIs.io has no affiliation with any venue.